Objective: Pyelonephritis has a more severe course during pregnancy than in the non-pregnant state. This has been attributed to the increased susceptibility of pregnant women to microbial products. An acquired protein Z deficiency has been reported when there is excessive thrombin activity. The aim of this study was to determine whether pyelonephritis during pregnancy is associated with changes in maternal plasma protein Z concentrations.

Study Design: A cross-sectional study was conducted to compare plasma protein Z concentrations between normal pregnant women (N = 71) and pregnant women with pyelonephritis (N = 42). Protein Z concentrations were measured by enzyme-linked immunosorbent assay. Parametric and non-parametric statistics were used for analysis.

Results: Patients with pyelonephritis had a significantly lower median plasma concentration of protein Z than did patients with normal pregnancies (median 2.14 microg/mL (0.4-3.4) vs. median 2.36 microg/mL (1.09-3.36); p = 0.03). There was no difference in the median plasma concentration of anti-protein Z antibodies between patients with pyelonephritis and those with normal pregnancies.

Conclusion: The median maternal plasma protein Z concentration was significantly lower in patients with pyelonephritis during pregnancy than in patients with normal pregnancies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136167PMC
http://dx.doi.org/10.1080/14767050802214659DOI Listing

Publication Analysis

Top Keywords

pyelonephritis pregnancy
12
pregnant women
12
plasma protein
12
patients pyelonephritis
12
maternal plasma
8
protein concentrations
8
median plasma
8
plasma concentration
8
patients normal
8
normal pregnancies
8

Similar Publications

Article Synopsis
  • Emphysematous pyelonephritis (EPN) is a severe urinary tract infection that can lead to high mortality rates, particularly in cases with underlying conditions, but it's rarely reported.
  • A 32-year-old pregnant woman with type 2 diabetes experienced worsening symptoms of pyelonephritis, leading to a diagnosis of EPN through imaging techniques.
  • Successful treatment involved antibiotic therapy, emphasizing the importance of early diagnosis and customized treatment approaches to safeguard both maternal and fetal health during pregnancy.
View Article and Find Full Text PDF

Pivmecillinam for Uncomplicated Acute Cystitis: A Contemporary Review.

Ann Pharmacother

December 2024

Department of Pharmacy Practice, ETSU Bill Gatton College of Pharmacy, East Tennessee State University, Johnson City, TN, USA.

Article Synopsis
  • - The review highlights the efficacy and safety of pivmecillinam in treating uncomplicated acute cystitis, based on data from six randomized controlled trials showing effectiveness at doses of 200 to 400 mg taken three times daily for 3 to 7 days.
  • - Higher doses (400 mg) and longer treatment durations resulted in better clinical and bacteriologic outcomes, while pivmecillinam is particularly beneficial for populations not commonly approved by the FDA, like men or pregnant women.
  • - As antibiotic resistance increases, pivmecillinam offers a new, potentially effective outpatient treatment option for uncomplicated acute cystitis in the U.S., with a focus on cost and its low resistance profile in managing uropathogens. *
View Article and Find Full Text PDF

Purpose: To evaluate possible problems during pregnancy or delivery in women with pediatric bladder augmentation.

Methods: Eleven of 59 women, who had undergone bladder augmentation in our pediatric hospital during 1990-2019, had given birth in our hospital district afterwards and their obstetrical records were evaluated.

Results: Median age at first delivery was 32 years (range 26-42).

View Article and Find Full Text PDF
Article Synopsis
  • * Timely diagnosis and appropriate antibacterial therapy (ABT) are essential for preventing adverse outcomes, with treatment varying based on the severity of the UTI; severe cases may require hospitalization and intravenous medications, while milder cases can be treated with oral drugs.
  • * For uncomplicated UTIs in pregnant women, effective oral ABT options include nitrofurans, fosfomycin trometamol, and third-generation cephalosporins, particularly cefixime, which is
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the obstetric outcomes and urological complications related to asymptomatic bacteriuria (AB) in pregnant women using different diagnostic criteria.
  • A total of 225 pregnant women participated, categorized into five groups based on their urine culture outcomes and treatment decisions, with factors like preterm birth and preeclampsia analyzed across these groups.
  • Findings indicated that preterm birth was more common in all groups with AB, while preeclampsia was particularly prevalent in certain groups, though no significant differences were noted in complications such as hypertension or amnionitis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!